Noah Berkowitz sold $74k of ARVN
Chief Medical Officer at ARVINAS, INC.. 8,658 shares at an average of $8.59, traded Mar 18, 2025, filed Mar 19, 2025.
Score components
- +15RoleOfficer
- +8Trade size$74k at market
- 0Share of holdings soldSold 7.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001655759-25-000064, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | SOpen-market sale Common Stock | -8,658 | $8.59 | $74k | 110,023 | Mar 19, 2025 |
Related signals
Other insiders at ARVINAS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $43k 5,700 shares | -3% | |
| 23Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $19k 2,583 shares | -2% | |
| 58Moderate | ARVINAS, INC. | John G Houston President and CEO | $524k 31,338 shares | -3% | |
| 46Moderate | ARVINAS, INC. | Ian Taylor President, R&D | $151k 9,020 shares | -5% | |
| 38Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $70k 4,207 shares | -4% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $20k 1,214 shares | -6% | |
| 15Weak | ARVNsell ARVINAS, INC. | David K Loomis Chief Accounting Officer | $10k 460 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.